Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioimmunoassay for metabolites of 9,3''-diacetylmidecamycin, a macrolide antibiotic

Journal Article · · Antimicrob. Agents Chemother.; (United States)
DOI:https://doi.org/10.1128/AAC.22.6.976· OSTI ID:6256889
A radioimmunoassay system has been developed for the measurement of two major metabolites of 9,3''-diacetylmidecamycin, Mb-6 and Mb-12. A radioimmunoassay for Mb-6 was performed by using anti-Mb-6 serum and a (/sup 125/I)tyramined Mb-6 derivative as a radiolabeled antigen. The labeled antigen was prepared by the chloramine T method. The antiserum was obtained from a rabbit immunized with Mb-6 conjugated to bovine serum albumin. The obtained antiserum was cross-reactive with two other metabolites of 9,3''-diacetylmidecamycin, Mb-2 and Mb-12, in addition to Mb-6. This Mb-6 radioimmunoassay system could detect Mb-6 concentrations as low as 100 pg/ml of serum. The coefficients of variation were 4.5% (intra-assay) and 5.1% (inter-assay). A radioimmunoassay for Mb-12, using anti-midecamycin serum and a (/sup 125/I)tyramined-Mb-12 derivative, has also been developed. The antiserum was cross-reactive only with Mb-12 among the 9,3''-diacetylmidecamycin metabolites. This Mb-12 radioimmunoassay system could detect Mb-12 concentrations as low as 2 ng/ml. The intra- and inter-assay variances were 5.9 and 5.8%, respectively.
Research Organization:
Tokai Laboratory, Daiichi Pure Chemicals Co. Ltd., Ibaraki, Japan
OSTI ID:
6256889
Journal Information:
Antimicrob. Agents Chemother.; (United States), Journal Name: Antimicrob. Agents Chemother.; (United States) Vol. 22:6; ISSN AMACC
Country of Publication:
United States
Language:
English